HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pons herniation into skull base after cabergoline therapy of giant prolactinoma.

AbstractINTRODUCTION:
Pons herniation after cabergoline therapy for giant prolactinoma is a complication not documented in literature.
CASE REPORT:
We report a medium aged patient who developed secondary hemiparesis after 18 months of medical treatment. MRI revealed pons herniation into the clivus. There was improvement with conservative treatment. Secuencial MRIs are presented showing the tumor at the moment of the diagnosis, tumor shrinkage and pons herniation.
DISCUSSION:
Some studies have shown that a significant and rapid tumor shrinkage resulting from treatment with cabergoline can occur and it is thought that some complications are related with this tumor regression, as in the presented case.
AuthorsJesús Moles Herbera, David Rivero Celada, Inmaculada Montejo Gañan, David Fustero de Miguel, Carlos Fuentes Uliaque, Ana Carmen Vela Marín
JournalPituitary (Pituitary) Vol. 18 Issue 1 Pg. 68-71 (Feb 2015) ISSN: 1573-7403 [Electronic] United States
PMID24522845 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents
  • Ergolines
  • Cabergoline
Topics
  • Antineoplastic Agents (therapeutic use)
  • Cabergoline
  • Ergolines (therapeutic use)
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Pituitary Neoplasms (drug therapy, pathology)
  • Pons (pathology)
  • Prolactinoma (drug therapy, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: